Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

In an effort to better serve our users, we have streamlined our content offering. As a result, we no longer publish new content or update existing content in Brain Cancer. Visit the 'Content & Subscriptions' tab of your Settings page at any time to update your Dashboard or Newsletter Subscription preferences to continue to see news and information that interests you most.

Published in Brain Cancer

Expert Opinion / Cases · September 29, 2022

Very high TMB in an IDH-wt recurrent glioblastoma

Gabriel Batistella


Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Gabriel Novaes de Rezende Batistella

    Sep 29, 2022

    Update: MGMT unmethylated (PCR with MethyLight)

  • Jayaprakash Madhavan

    Oct 03, 2022

    Consider Immune check point inhibition 

  • Dron Gauchan

    Nov 28, 2022

    I would use both temozolamide for 6 months and Immunotherapy together for atheist 2 years if tolerated. 

  • Nov 30, 2023

    Pending Moderator approval.

Further Reading